Modeling Short QT Syndrome Using Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes


Patient-specific hiPSC-CMs are able to recapitulate single-cell phenotype features of SQTS and provide novel opportunities to further elucidate the cellular disease mechanism and test drug effects. © 2018 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley.

Authors El-Battrawy I, Lan H, Cyganek L, Zhao Z, Li X, Buljubasic F, Lang S, Yücel G, Sattler K, Zimmermann WH, Utikal J, Wieland T, Ravens U, Borggrefe M, Zhou XB, Akin I
Journal Journal of the American Heart Association
Publication Date 2018 Mar 24;7(7)
PubMed 29574456
PubMed Central PMC5907581
DOI 10.1161/jaha.117.007394

Research Projects

Cell Lines